Page last updated: 2024-09-03

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and hki 272

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with hki 272 in 1 studies

Compound Research Comparison

Studies
(4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide)
Trials
(4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide)
Recent Studies (post-2010)
(4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide)
Studies
(hki 272)
Trials
(hki 272)
Recent Studies (post-2010) (hki 272)
6201428342248

Protein Interaction Comparison

ProteinTaxonomy4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide (IC50)hki 272 (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.0416
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)0.0298
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.8582
Serine/threonine-protein kinase Nek2Homo sapiens (human)0.274

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR1

Other Studies

1 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and hki 272

ArticleYear
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
    Bioorganic & medicinal chemistry, 2019, 07-15, Volume: 27, Issue:14

    Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility

2019